{"hits":{"4_55593661_T_C":{"matched":0,"disease_name":"pancancer","id":"4_55593661_T_C","gene":"KIT:p.L572P, KIT:p.L573P, KIT:p.L576P, KIT:p.L577P","cell":0,"overlap":31,"diagnostic":0,"disease":"pancancer","mtct_score":"37.76","hit":12},"12_25398284_C_A":{"disease_name":"pancancer","matched":8,"id":"12_25398284_C_A","gene":"KRAS:p.G12V","disease":"pancancer","diagnostic":0,"overlap":87,"cell":4,"hit":9,"mtct_score":"54.32"},"9_133748283_C_T":{"disease_name":"pancancer","matched":3,"gene":"ABL1:p.T334I, ABL1:p.T315I, ABL1:p.T333I","id":"9_133748283_C_T","disease":"pancancer","overlap":15,"cell":0,"diagnostic":0,"hit":13,"mtct_score":"68.18"},"9_5073770_G_T":{"disease":"pancancer","diagnostic":0,"cell":0,"overlap":4,"hit":5,"mtct_score":"26.10","disease_name":"pancancer","matched":0,"gene":"JAK2:p.V617F","id":"9_5073770_G_T"},"7_55259515_T_G":{"disease":"pancancer","diagnostic":0,"overlap":26,"cell":0,"hit":18,"mtct_score":"125.48","disease_name":"pancancer","matched":0,"id":"7_55259515_T_G","gene":"EGFR:p.L813R, EGFR:p.L805R, EGFR:p.L858R"},"7_140453136_A_C":{"matched":60,"disease_name":"pancancer","gene":"BRAF:p.V600G","id":"7_140453136_A_C","cell":7,"overlap":32,"diagnostic":0,"disease":"pancancer","mtct_score":"71.83","hit":2}},"drug":{"increased":{"Pegylated IFN-alpha-2a":{"confidence_level":"Clinical trial stage","associated_protein_effect":["JAK2:p.V617F"],"hits":["3154"],"disease":"pancancer","disease_name":"pancancer","associated_mutation":["chr9:g.5073770G>T"],"drug_name":"Pegylated IFN-alpha-2a"},"Bevacizumab":{"drug_name":"Bevacizumab","associated_mutation":["chr7:g.140453136A>C"],"disease_name":"pancancer","disease":"pancancer","hits":["1529"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Preclinical stage"},"Osimertinib":{"associated_mutation":["chr7:g.55259515T>G"],"drug_name":"Osimertinib","disease":"pancancer","disease_name":"pancancer","hits":["3488"],"confidence_level":"Proven","associated_protein_effect":["EGFR:p.L858R"]},"Irreversible EGFR TKIs":{"confidence_level":"Clinical trial stage","associated_protein_effect":["EGFR:p.L858R"],"hits":["800"],"disease":"pancancer","disease_name":"pancancer","drug_name":"Irreversible EGFR TKIs","associated_mutation":["chr7:g.55259515T>G"]},"RO4987655":{"disease":"pancancer","disease_name":"pancancer","associated_mutation":["chr7:g.140453136A>C"],"drug_name":"RO4987655","confidence_level":"Clinical trial stage","associated_protein_effect":["BRAF:p.V600G"],"hits":["1198"]},"Ruxolitinib":{"hits":["4045","1843"],"associated_protein_effect":["JAK2:p.V617F"],"confidence_level":"Proven","drug_name":"Ruxolitinib","associated_mutation":["chr9:g.5073770G>T"],"disease_name":"pancancer","disease":"pancancer"},"Dacomitinib":{"associated_protein_effect":["EGFR:p.L858R"],"confidence_level":"Proven","hits":["2510"],"disease_name":"pancancer","disease":"pancancer","associated_mutation":["chr7:g.55259515T>G"],"drug_name":"Dacomitinib"},"Docetaxel":{"drug_name":"Docetaxel","associated_mutation":["chr12:g.25398284C>A"],"disease":"pancancer","disease_name":"pancancer","hits":["401"],"confidence_level":"Clinical trial stage","associated_protein_effect":["KRAS:p.G12V"]},"AURK inhibitors + BCR-ABL1 inhibitors":{"associated_mutation":["chr9:g.133748283C>T"],"drug_name":"AURK inhibitors + BCR-ABL1 inhibitors","disease":"pancancer","disease_name":"pancancer","hits":["2378"],"confidence_level":"Case report stage","associated_protein_effect":["ABL1:p.T315I"]},"BEZ235 (NVP-BEZ235)":{"disease":"pancancer","disease_name":"pancancer","associated_mutation":["chr7:g.140453136A>C","chr12:g.25398284C>A"],"drug_name":"BEZ235 (NVP-BEZ235)","confidence_level":"Preclinical stage","associated_protein_effect":["BRAF:p.V600G","KRAS:p.G12V"],"hits":["2516","33","300"]},"Axitinib":{"hits":["3565"],"associated_protein_effect":["ABL1:p.T315I"],"confidence_level":"Case report stage","associated_mutation":["chr9:g.133748283C>T"],"drug_name":"Axitinib","disease_name":"pancancer","disease":"pancancer"},"Capecitabine":{"disease":"pancancer","disease_name":"pancancer","drug_name":"Capecitabine","associated_mutation":["chr7:g.140453136A>C"],"confidence_level":"Preclinical stage","associated_protein_effect":["BRAF:p.V600G"],"hits":["2179"]},"Neratinib":{"confidence_level":"Proven","associated_protein_effect":["EGFR:p.L858R"],"hits":["1960"],"disease":"pancancer","disease_name":"pancancer","drug_name":"Neratinib","associated_mutation":["chr7:g.55259515T>G"]},"Selumetinib + radioactive iodine therapy":{"hits":["1589"],"associated_protein_effect":["KRAS:p.G12V"],"confidence_level":"Clinical trial stage","associated_mutation":["chr12:g.25398284C>A"],"drug_name":"Selumetinib + radioactive iodine therapy","disease_name":"pancancer","disease":"pancancer"},"PLX4720":{"hits":["36"],"confidence_level":"Preclinical stage","associated_protein_effect":["BRAF:p.V600G"],"drug_name":"PLX4720","associated_mutation":["chr7:g.140453136A>C"],"disease":"pancancer","disease_name":"pancancer"},"Rociletinib":{"disease_name":"pancancer","disease":"pancancer","drug_name":"Rociletinib","associated_mutation":["chr7:g.55259515T>G"],"associated_protein_effect":["EGFR:p.L858R"],"confidence_level":"Proven","hits":["1881"]},"Sunitinib":{"hits":["3635"],"confidence_level":"Case report stage","associated_protein_effect":["KIT:p.L576P"],"associated_mutation":["chr4:g.55593661T>C"],"drug_name":"Sunitinib","disease":"pancancer","disease_name":"pancancer"},"TG101348":{"hits":["260"],"associated_protein_effect":["JAK2:p.V617F"],"confidence_level":"Preclinical stage","associated_mutation":["chr9:g.5073770G>T"],"drug_name":"TG101348","disease_name":"pancancer","disease":"pancancer"},"Cobimetinib":{"disease_name":"pancancer","disease":"pancancer","drug_name":"Cobimetinib","associated_mutation":["chr7:g.140453136A>C"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Clinical trial stage","hits":["1087","988","1284"]},"ARRY-142886":{"disease_name":"pancancer","disease":"pancancer","drug_name":"ARRY-142886","associated_mutation":["chr12:g.25398284C>A"],"associated_protein_effect":["KRAS:p.G12V"],"confidence_level":"Preclinical stage","hits":["3037"]},"Pictilisib":{"drug_name":"Pictilisib","associated_mutation":["chr7:g.140453136A>C"],"disease":"pancancer","disease_name":"pancancer","hits":["3616"],"confidence_level":"Case report stage","associated_protein_effect":["BRAF:p.V600G"]},"Afatinib":{"associated_mutation":["chr7:g.55259515T>G"],"drug_name":"Afatinib","disease_name":"pancancer","disease":"pancancer","hits":["3330","3337","4301"],"associated_protein_effect":["EGFR:p.L858R"],"confidence_level":"Proven"},"Nutlin-3":{"drug_name":"Nutlin-3","associated_mutation":["chr7:g.140453136A>C"],"disease_name":"pancancer","disease":"pancancer","hits":["1921"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Preclinical stage"},"JAK inhibitors (alone or in combination)":{"hits":["2619"],"confidence_level":"Preclinical stage","associated_protein_effect":["JAK2:p.V617F"],"drug_name":"JAK inhibitors (alone or in combination)","associated_mutation":["chr9:g.5073770G>T"],"disease":"pancancer","disease_name":"pancancer"},"Afatinib + cetuximab":{"disease":"pancancer","disease_name":"pancancer","drug_name":"Afatinib + cetuximab","associated_mutation":["chr7:g.55259515T>G"],"confidence_level":"Clinical trial stage","associated_protein_effect":["EGFR:p.L858R"],"hits":["1461"]},"PD0332991":{"associated_protein_effect":["KRAS:p.G12V"],"confidence_level":"Preclinical stage","hits":["4385"],"disease_name":"pancancer","disease":"pancancer","associated_mutation":["chr12:g.25398284C>A"],"drug_name":"PD0332991"},"HSP90 inhibitors":{"drug_name":"HSP90 inhibitors","associated_mutation":["chr7:g.55259515T>G"],"disease_name":"pancancer","disease":"pancancer","hits":["2134"],"associated_protein_effect":["EGFR:p.L858R"],"confidence_level":"Clinical trial stage"},"MK-2206":{"drug_name":"MK-2206","associated_mutation":["chr12:g.25398284C>A"],"disease_name":"pancancer","disease":"pancancer","hits":["3461"],"associated_protein_effect":["KRAS:p.G12V"],"confidence_level":"Case report stage"},"GDC-0879":{"associated_mutation":["chr7:g.140453136A>C"],"drug_name":"GDC-0879","disease_name":"pancancer","disease":"pancancer","hits":["225"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Preclinical stage"},"Selumetinib (AZD6244)":{"associated_protein_effect":["BRAF:p.V600G","KRAS:p.G12V"],"confidence_level":"Clinical trial stage","hits":["2935","3317"],"disease_name":"pancancer","disease":"pancancer","drug_name":"Selumetinib (AZD6244)","associated_mutation":["chr7:g.140453136A>C","chr12:g.25398284C>A"]},"Dactolisib":{"associated_protein_effect":["KRAS:p.G12V","BRAF:p.V600G"],"confidence_level":"Preclinical stage","hits":["1988","3108","3619"],"disease_name":"pancancer","disease":"pancancer","drug_name":"Dactolisib","associated_mutation":["chr12:g.25398284C>A","chr7:g.140453136A>C"]},"Everolimus":{"hits":["2133"],"associated_protein_effect":["KIT:p.L576P"],"confidence_level":"Case report stage","associated_mutation":["chr4:g.55593661T>C"],"drug_name":"Everolimus","disease_name":"pancancer","disease":"pancancer"},"BRAF inhibitors":{"disease":"pancancer","disease_name":"pancancer","drug_name":"BRAF inhibitors","associated_mutation":["chr7:g.140453136A>C"],"confidence_level":"Clinical trial stage","associated_protein_effect":["BRAF:p.V600G"],"hits":["4334"]},"MEK inhibitors (alone or in combination)":{"confidence_level":"Preclinical stage","associated_protein_effect":["EGFR:p.L858R"],"hits":["3311"],"disease":"pancancer","disease_name":"pancancer","associated_mutation":["chr7:g.55259515T>G"],"drug_name":"MEK inhibitors (alone or in combination)"},"Ponatinib":{"associated_mutation":["chr9:g.133748283C>T"],"drug_name":"Ponatinib","disease_name":"pancancer","disease":"pancancer","hits":["2652","566","6","1251"],"associated_protein_effect":["ABL1:p.T333I","ABL1:p.T334I","ABL1:p.T315I"],"confidence_level":"Proven"}},"reduced":{"Anti-EGFR antibody therapy + chemotherapy":{"hits":["4597"],"confidence_level":"Clinical trial stage","associated_protein_effect":["KRAS:p.G12V"],"drug_name":"Anti-EGFR antibody therapy + chemotherapy","associated_mutation":["chr12:g.25398284C>A"],"disease":"pancancer","disease_name":"pancancer"},"Crizotinib":{"hits":["600"],"associated_protein_effect":["KRAS:p.G12V"],"confidence_level":"Case report stage","drug_name":"Crizotinib","associated_mutation":["chr12:g.25398284C>A"],"disease_name":"pancancer","disease":"pancancer"},"Bosutinib":{"associated_mutation":["chr9:g.133748283C>T"],"drug_name":"Bosutinib","disease_name":"pancancer","disease":"pancancer","hits":["107","122"],"associated_protein_effect":["ABL1:p.T315I"],"confidence_level":"Clinical trial stage"},"BAY 86-9766":{"drug_name":"BAY 86-9766","associated_mutation":["chr7:g.140453136A>C"],"disease_name":"pancancer","disease":"pancancer","hits":["3653"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Case report stage"},"Sorafenib":{"hits":["3851","3649"],"confidence_level":"Preclinical stage","associated_protein_effect":["KIT:p.L577P","KIT:p.L576P","KIT:p.L573P","BRAF:p.V600G","KIT:p.L572P"],"drug_name":"Sorafenib","associated_mutation":["chr4:g.55593661T>C","chr7:g.140453136A>C"],"disease":"pancancer","disease_name":"pancancer"}},"conflict":{"Dabrafenib":{"associated_mutation":["chr7:g.140453136A>C"],"drug_name":"Dabrafenib","disease_name":"pancancer","disease":"pancancer","hits":["3828","3580","754","2189","3420","1024","3664"],"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Proven"},"Dasatinib":{"associated_mutation":["chr4:g.55593661T>C","chr9:g.133748283C>T"],"drug_name":"Dasatinib","disease_name":"pancancer","disease":"pancancer","hits":["3593","2451","1612","403"],"associated_protein_effect":["KIT:p.L572P","ABL1:p.T315I","KIT:p.L573P","KIT:p.L576P","KIT:p.L577P"],"confidence_level":"Clinical trial stage"},"Nilotinib":{"confidence_level":"Clinical trial stage","associated_protein_effect":["KIT:p.L576P","KIT:p.L577P","KIT:p.L572P","ABL1:p.T315I","KIT:p.L573P"],"hits":["2364","4130","761","4679","3680"],"disease":"pancancer","disease_name":"pancancer","drug_name":"Nilotinib","associated_mutation":["chr9:g.133748283C>T","chr4:g.55593661T>C"]},"Vemurafenib":{"disease_name":"pancancer","disease":"pancancer","associated_mutation":["chr7:g.140453136A>C","chr12:g.25398284C>A"],"drug_name":"Vemurafenib","associated_protein_effect":["BRAF:p.V600G","KRAS:p.G12V"],"confidence_level":"Proven","hits":["4396","1602","1217","3818","1125","1987","342","2326","4694","3070","2087","2332","329","1161","1004","1038","3886","1355","2694","2298"]},"Panitumumab":{"associated_mutation":["chr12:g.25398284C>A","chr7:g.140453136A>C"],"drug_name":"Panitumumab","disease_name":"pancancer","disease":"pancancer","hits":["135","2871","123","2221","686"],"associated_protein_effect":["KRAS:p.G12V","BRAF:p.V600G"],"confidence_level":"Clinical trial stage"},"Trametinib":{"associated_protein_effect":["BRAF:p.V600G"],"confidence_level":"Proven","hits":["2884","2747","1463","3526","1737","3581"],"disease_name":"pancancer","disease":"pancancer","associated_mutation":["chr7:g.140453136A>C"],"drug_name":"Trametinib"},"Imatinib":{"associated_protein_effect":["KIT:p.L576P","ABL1:p.T333I","KIT:p.L577P","KIT:p.L572P","ABL1:p.T315I","KIT:p.L573P","ABL1:p.T334I"],"confidence_level":"Clinical trial stage","hits":["460","3672","986","817","1140","2584","777","1265"],"disease_name":"pancancer","disease":"pancancer","drug_name":"Imatinib","associated_mutation":["chr4:g.55593661T>C","chr9:g.133748283C>T"]},"Erlotinib":{"disease_name":"pancancer","disease":"pancancer","drug_name":"Erlotinib","associated_mutation":["chr7:g.55259515T>G","chr12:g.25398284C>A"],"associated_protein_effect":["EGFR:p.L858R","KRAS:p.G12V"],"confidence_level":"Proven","hits":["2292","4017","2021"]},"Gefitinib":{"associated_protein_effect":["EGFR:p.L858R","KRAS:p.G12V","BRAF:p.V600G"],"confidence_level":"Proven","hits":["4169","3005","3431","2552","1353"],"disease_name":"pancancer","disease":"pancancer","drug_name":"Gefitinib","associated_mutation":["chr7:g.140453136A>C","chr7:g.55259515T>G","chr12:g.25398284C>A"]},"PD0325901":{"hits":["1218","1742"],"confidence_level":"Preclinical stage","associated_protein_effect":["BRAF:p.V600G"],"drug_name":"PD0325901","associated_mutation":["chr7:g.140453136A>C"],"disease":"pancancer","disease_name":"pancancer"},"Cetuximab":{"associated_protein_effect":["BRAF:p.V600G","KRAS:p.G12V"],"confidence_level":"Clinical trial stage","hits":["826","477","3002","3396","2914","333"],"disease_name":"pancancer","disease":"pancancer","drug_name":"Cetuximab","associated_mutation":["chr7:g.140453136A>C","chr12:g.25398284C>A"]}}},"task_name":"1","workspace_name":"mtct-1641385860"}